Tower Research Capital (TRC)’s Rallybio RLYB Stock Holding History
Bought
Maintained
Sold
Other funds holding RLYB
CAM
TGA
LCM
NCM
PBPIA
5VM
AC
Tower Research Capital (TRC)'s RLYB Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Rallybio (RLYB) stake by 60% in Q1 2026, buying an estimated $2.33K and bringing the position to 907 shares worth $8.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3984.
Tower Research Capital (TRC) first reported a position in RLYB in Q3 2021 and has held it in 19 quarters since. The position peaked at $46K in Q3 2022. 38 funds tracked by Wall St. Rank hold RLYB as of Q1 2026.
- Tower Research Capital (TRC) held 907 shares of Rallybio worth $8.14K as of Q1 2026.
- Tower Research Capital (TRC) bought 341 Rallybio shares in Q1 2026, an estimated $2.33K.
- Rallybio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #3984 holding.
- Tower Research Capital (TRC) first reported a position in Rallybio in Q3 2021 and has held it in 19 quarters since.
- Tower Research Capital (TRC)'s Rallybio position peaked at $46K in Q3 2022.
- 38 funds tracked by Wall St. Rank held Rallybio as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.